V
VALN
Valneva Se
6.96
+0.14+2.05%After Hours: 6.96 0.00 0.00%16:10 08/21 EDT
OPEN/PREV CLOSE6.77/6.82
TODAY RANGE6.71-7.06
VOL21.59K
MARKET CAP659.97M
52 WEEK RANGE4.750-12.25
AVG VOL (3M)77.91K
% TURNOVER0.02%
TURNOVER--
P/E (TTM)-7.0955
% RANGE5.07%
EPS(TTM)-0.9809
P/E(FORWARD)-6.2198
P/B6.83
BVPS1.019
DIVIDEND--
P/S2.942
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP644.02M
SHARES OUTSTANDING94.82M
NEXT EARNINGS11/12-11/27
FREE FLOAT92.53M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Valneva: The Lyme Royalty Transition Changes The Earnings Model
TipRanks·08/16 13:55
Pfizer, Valneva announce EMA validation for PF-07307405 MAA
TipRanks·08/16 12:59
Midday Fly By: Applied Materials reports Q3 beat, Trump slaps tariffs on drones
Benzinga·08/14 16:46
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application
Benzinga·08/14 16:02
Dow Falls Over 100 Points; US Consumer Sentiment Declines In August
Benzinga·08/14 13:55
Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday
TipRanks·08/14 13:47
Valneva Stock (VLN) Soars Over 20% On Lyme Disease Vaccine Hopes
Dow Jones·08/14 12:40
Valneva Shares Climb After Lyme Disease Vaccine Receives EMA Application Acceptance
TipRanks·08/14 12:18
Guggenheim Reaffirms Their Buy Rating on Valneva (VALN)
Benzinga·08/14 12:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Seeking Alpha·08/14 10:46
Valneva jumps as Lyme disease vaccine developed with Pfizer undergoes EU review
NASDAQ·08/14 10:44
Pfizer And Valneva's Lyme Vaccine Clears EMA Review Gate
Benzinga·08/14 08:37
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
NASDAQ·08/14 07:26
Pfizer, Valneva's Lyme Disease Vaccine Application Validated By EMA